JP2016521539A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016521539A5 JP2016521539A5 JP2015558676A JP2015558676A JP2016521539A5 JP 2016521539 A5 JP2016521539 A5 JP 2016521539A5 JP 2015558676 A JP2015558676 A JP 2015558676A JP 2015558676 A JP2015558676 A JP 2015558676A JP 2016521539 A5 JP2016521539 A5 JP 2016521539A5
- Authority
- JP
- Japan
- Prior art keywords
- virus
- particle
- antigen
- malaria
- nucleic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361830436P | 2013-06-03 | 2013-06-03 | |
| US61/830,436 | 2013-06-03 | ||
| US201361906583P | 2013-11-20 | 2013-11-20 | |
| US61/906,583 | 2013-11-20 | ||
| PCT/JP2014/065166 WO2014196648A1 (en) | 2013-06-03 | 2014-06-02 | Malaria vaccine |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016521539A JP2016521539A (ja) | 2016-07-25 |
| JP2016521539A5 true JP2016521539A5 (enExample) | 2017-07-06 |
| JP6734651B2 JP6734651B2 (ja) | 2020-08-05 |
Family
ID=52005658
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015558676A Active JP6734651B2 (ja) | 2013-06-03 | 2014-06-02 | マラリアワクチン |
Country Status (16)
| Country | Link |
|---|---|
| US (3) | US9512190B2 (enExample) |
| EP (1) | EP3004348B1 (enExample) |
| JP (1) | JP6734651B2 (enExample) |
| KR (2) | KR20160016856A (enExample) |
| CN (1) | CN105431535A (enExample) |
| AP (1) | AP2015008926A0 (enExample) |
| AU (1) | AU2014275772B2 (enExample) |
| BR (1) | BR112015030229B1 (enExample) |
| CA (1) | CA2913832C (enExample) |
| IL (1) | IL242656B (enExample) |
| MX (1) | MX386234B (enExample) |
| RU (1) | RU2702163C2 (enExample) |
| SG (2) | SG11201509614SA (enExample) |
| TW (1) | TWI687442B (enExample) |
| WO (1) | WO2014196648A1 (enExample) |
| ZA (1) | ZA201508642B (enExample) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ717682A (en) | 2012-02-16 | 2017-10-27 | Vlp Therapeutics Llc | Virus like particle composition |
| TWI676636B (zh) | 2013-07-12 | 2019-11-11 | Ｖｌｐ醫療股份有限公司 | 包含ｐｄ－１抗原或ｐｄ－１配體抗原的類病毒粒子 |
| CN106795513B (zh) | 2014-08-08 | 2021-06-11 | Vlp治疗公司 | 包含修饰的包膜蛋白e3的病毒样颗粒 |
| US10385101B2 (en) | 2014-08-08 | 2019-08-20 | Vlp Therapeutics, Llc | Virus like particle comprising modified envelope protein E3 |
| CN106687590B (zh) | 2014-09-11 | 2021-08-03 | Vlp治疗公司 | 黄热病毒病毒样颗粒 |
| US10166281B2 (en) * | 2015-09-04 | 2019-01-01 | Vlp Therapeutics, Llc | Method and composition for modulating immune response |
| US9968665B2 (en) * | 2015-09-16 | 2018-05-15 | Artificial Cell Technologies, Inc. | Anti-malaria compositions and methods |
| CN110945022B (zh) | 2017-04-19 | 2024-04-05 | 生物医学研究所 | 作为疫苗及新疟疾疫苗和抗体结合靶标的疟原虫子孢子npdp肽 |
| TW201907937A (zh) | 2017-05-08 | 2019-03-01 | 美商葛利史東腫瘤科技公司 | 阿爾法病毒新抗原載體 |
| SG11202005792RA (en) | 2017-12-20 | 2020-07-29 | Vlp Therapeutics Llc | Alphavirus replicon particle |
| JP7653013B2 (ja) | 2018-01-04 | 2025-03-28 | アイコニック セラピューティクス リミテッド ライアビリティ カンパニー | 抗組織因子抗体、抗体薬物コンジュゲート、及び関連する方法 |
| CN109536464B (zh) * | 2018-12-10 | 2022-06-10 | 中国科学院武汉病毒研究所 | 一种缺失衣壳蛋白基因的基孔肯雅病毒感染性克隆及构建方法和在制备减毒疫苗中的应用 |
| MX2021014525A (es) | 2019-05-30 | 2022-03-17 | Gritstone Bio Inc | Adenovirus modificados. |
| EP4135847A4 (en) | 2020-04-17 | 2024-05-15 | VLP Therapeutics, Inc. | Coronavirus vaccine |
| WO2021221127A1 (en) | 2020-04-30 | 2021-11-04 | Vlp Therapeutics, Inc. | Cytokine immunotherapy |
| EP4192496A4 (en) | 2020-08-06 | 2025-01-01 | Gritstone bio, Inc. | MULTIEPITOP VACCINE CASSETTES |
| EP4436988A4 (en) * | 2021-11-22 | 2025-04-16 | Novavax AB | METHODS AND COMPOSITIONS FOR THE TREATMENT AND PREVENTION OF MALARIA |
| WO2025064770A2 (en) * | 2023-09-20 | 2025-03-27 | La Jolla Institute of Immunology | Alphavirus t cell epitopes, megapools and uses thereof |
| WO2025084276A1 (ja) * | 2023-10-16 | 2025-04-24 | Ｃｙｎ－Ｋバイオ株式会社 | 肥満の処置 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2123612C (en) * | 1991-11-16 | 2002-06-25 | Michel De Wilde | Hybrid protein between cs from plasmodium and h bsag |
| US20050031592A1 (en) * | 2002-11-13 | 2005-02-10 | Doolan Denise L. | Methods and compositions for inducing immune responses and protective immunity by priming with alpha virus replicon vaccines |
| ES2371175T3 (es) * | 2004-10-14 | 2011-12-28 | Crucell Holland B.V. | Vacunas de sensibilización/refuerzo de malaria. |
| GB0513421D0 (en) * | 2005-06-30 | 2005-08-03 | Glaxosmithkline Biolog Sa | Vaccines |
| US20100120092A1 (en) * | 2006-08-30 | 2010-05-13 | Hepgenics Pty Ltd. | Recombinant proteins and virus like particles comprising l and s polypeptides of avian hepadnaviridae and methods, nucleic acid constructs, vectors and host cells for producing same |
| SG171828A1 (en) | 2008-11-26 | 2011-07-28 | Us Gov Health & Human Serv | Virus like particle compositions and methods of use |
| WO2011022002A1 (en) * | 2009-08-18 | 2011-02-24 | The Rockefeller University | Modification of recombinant adenovirus with immunogenic plasmodium circumsporozoite protein epitopes |
| ES2752323T3 (es) * | 2009-09-18 | 2020-04-06 | Fraunhofer Usa Inc | Partículas de tipo virus que comprenden proteínas diana fusionadas a proteínas de revestimiento de virus vegetales |
| WO2012006180A1 (en) * | 2010-06-29 | 2012-01-12 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Hiv immunogens |
| WO2012023995A1 (en) * | 2010-08-18 | 2012-02-23 | Takayuki Shiratsuchi | Modification of recombinant adenovirus capsid protein with immunogenic plasmodium circumsporozoite protein epitopes |
| WO2012106356A2 (en) * | 2011-01-31 | 2012-08-09 | GOVERNMENT OF THE USA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH & HUMAN SERVICES | Virus-like particles and methods of use |
| NZ717682A (en) * | 2012-02-16 | 2017-10-27 | Vlp Therapeutics Llc | Virus like particle composition |
| CN106795513B (zh) | 2014-08-08 | 2021-06-11 | Vlp治疗公司 | 包含修饰的包膜蛋白e3的病毒样颗粒 |
-
2014
- 2014-06-02 CN CN201480043750.5A patent/CN105431535A/zh active Pending
- 2014-06-02 WO PCT/JP2014/065166 patent/WO2014196648A1/en not_active Ceased
- 2014-06-02 AU AU2014275772A patent/AU2014275772B2/en not_active Ceased
- 2014-06-02 SG SG11201509614SA patent/SG11201509614SA/en unknown
- 2014-06-02 CA CA2913832A patent/CA2913832C/en active Active
- 2014-06-02 KR KR1020157035411A patent/KR20160016856A/ko not_active Ceased
- 2014-06-02 KR KR1020217029655A patent/KR102494564B1/ko active Active
- 2014-06-02 EP EP14807026.1A patent/EP3004348B1/en active Active
- 2014-06-02 IL IL242656A patent/IL242656B/en unknown
- 2014-06-02 RU RU2015155821A patent/RU2702163C2/ru active
- 2014-06-02 MX MX2015016627A patent/MX386234B/es unknown
- 2014-06-02 AP AP2015008926A patent/AP2015008926A0/xx unknown
- 2014-06-02 SG SG10201709917VA patent/SG10201709917VA/en unknown
- 2014-06-02 JP JP2015558676A patent/JP6734651B2/ja active Active
- 2014-06-02 BR BR112015030229-7A patent/BR112015030229B1/pt not_active IP Right Cessation
- 2014-06-03 US US14/294,968 patent/US9512190B2/en active Active
- 2014-06-03 TW TW103119188A patent/TWI687442B/zh not_active IP Right Cessation
-
2015
- 2015-11-24 ZA ZA2015/08642A patent/ZA201508642B/en unknown
-
2016
- 2016-10-21 US US15/299,859 patent/US20170035871A1/en not_active Abandoned
-
2019
- 2019-03-28 US US16/367,374 patent/US20190351041A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015508648A5 (enExample) | ||
| EP3177720B1 (en) | Virus like particle comprising modified envelope protein e3 | |
| RU2014133527A (ru) | Композиция вирусоподобных частиц | |
| US10464986B2 (en) | Virus like particle comprising PD-1 antigen or PD-1 ligand antigen | |
| AU2014275772B2 (en) | Malaria vaccine | |
| US10385101B2 (en) | Virus like particle comprising modified envelope protein E3 | |
| JP2016501535A5 (enExample) | ||
| EP3601367A1 (en) | "chimeric molecules and uses thereof" | |
| RU2016145464A (ru) | Рекомбинантные вакцинные штаммы listeria и способы их получения | |
| JP2017513502A5 (enExample) | ||
| O’Rourke et al. | Affinity selection of epitope-based vaccines using a bacteriophage virus-like particle platform | |
| RU2017132190A (ru) | Гибридные белки, содержащие модифицированные поверхностные гликопротеины альфавируса и опухолеассоциированный антиген, и способы, связанные с ними | |
| CN102112601A (zh) | 新的融合蛋白及其用于制备针对丙型肝炎的疫苗的用途 | |
| JP2009522368A5 (enExample) | ||
| CN107074968B (zh) | 疫苗 | |
| JP2024540894A5 (enExample) | ||
| JP2024533123A5 (enExample) | ||
| TH112180A (th) | โปรตีนผสมชนิดใหม่ ๆ และการใช้โปรตีนเหล่านี้เพื่อการเตรียมวัคซีนต้านไวรัสตับอักเสบ ซี | |
| CN101502657A (zh) | 噬菌体与EB病毒的gp350蛋白融合载体疫苗的构建方法 | |
| Honjo | New flavivirus antigens for production of vaccines against Japanese encep/ml~ pimmid vector mmtrucflon and gem in Esdm, iehia coil Res. Found. Microbial Dis. Osaka Univ. Belgium; 16 March 1987 | |
| TW201219571A (en) | Method for recombinant botulinum neurotoxin a vaccine production by baculovirus expression system and vaccine thereof |